🔎 Trials Near Me

Home › Squamous Cell Carcinoma › Virginia

Pag-aaral pangklinika para sa Squamous Cell Carcinoma sa Virginia

6 pag-aaral para sa Squamous Cell Carcinoma ang naghahanap ng mga kalahok sa mga site sa Virginia.

Mga Lungsod sa Virginia

Opisyal na teksto ng pag-aaral (English)

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

  • University of Virginia, Charlottesville
  • Macon Joan Brock Virginia Health Sciences Eastern Virginia Medical Group at Old Dominion University, Norfolk
Nagre-recruitPhase 3
Edad 60 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04892173

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

  • USO-Virginia Cancer Specialists, PC, Fairfax
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06561685

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

  • Inova Schar Cancer Center, Fairfax
Nagre-recruitPhase 2
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT04915183

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

  • Research Site, Fairfax
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT07115043

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

  • VCU Massey Cancer Center, Richmond
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 9, 2026 · NCT06064877

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

  • Virginia Cancer Specialists, Fairfax
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2025 · NCT04370587

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.